These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 21410436

  • 1. Biochemical characterization of human HIF hydroxylases using HIF protein substrates that contain all three hydroxylation sites.
    Pappalardi MB, McNulty DE, Martin JD, Fisher KE, Jiang Y, Burns MC, Zhao H, Ho T, Sweitzer S, Schwartz B, Annan RS, Copeland RA, Tummino PJ, Luo L.
    Biochem J; 2011 Jun 01; 436(2):363-9. PubMed ID: 21410436
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS, Schofield CJ, Ratcliffe PJ.
    Methods Enzymol; 2007 Jun 01; 435():25-42. PubMed ID: 17998047
    [Abstract] [Full Text] [Related]

  • 3. Determination and comparison of specific activity of the HIF-prolyl hydroxylases.
    Tuckerman JR, Zhao Y, Hewitson KS, Tian YM, Pugh CW, Ratcliffe PJ, Mole DR.
    FEBS Lett; 2004 Oct 08; 576(1-2):145-50. PubMed ID: 15474027
    [Abstract] [Full Text] [Related]

  • 4. Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis.
    Pappalardi MB, Martin JD, Jiang Y, Burns MC, Zhao H, Ho T, Sweitzer S, Lor L, Schwartz B, Duffy K, Gontarek R, Tummino PJ, Copeland RA, Luo L.
    Biochemistry; 2008 Oct 28; 47(43):11165-7. PubMed ID: 18834144
    [Abstract] [Full Text] [Related]

  • 5. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.
    Koivunen P, Hirsilä M, Günzler V, Kivirikko KI, Myllyharju J.
    J Biol Chem; 2004 Mar 12; 279(11):9899-904. PubMed ID: 14701857
    [Abstract] [Full Text] [Related]

  • 6. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.
    Dayan F, Roux D, Brahimi-Horn MC, Pouyssegur J, Mazure NM.
    Cancer Res; 2006 Apr 01; 66(7):3688-98. PubMed ID: 16585195
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors.
    Henze AT, Riedel J, Diem T, Wenner J, Flamme I, Pouyseggur J, Plate KH, Acker T.
    Cancer Res; 2010 Jan 01; 70(1):357-66. PubMed ID: 20028863
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. HIF-prolyl hydroxylases and cardiovascular diseases.
    Sen Banerjee S, Thirunavukkarasu M, Tipu Rishi M, Sanchez JA, Maulik N, Maulik G.
    Toxicol Mech Methods; 2012 Jun 01; 22(5):347-58. PubMed ID: 22424133
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The peptidyl prolyl cis/trans isomerase FKBP38 determines hypoxia-inducible transcription factor prolyl-4-hydroxylase PHD2 protein stability.
    Barth S, Nesper J, Hasgall PA, Wirthner R, Nytko KJ, Edlich F, Katschinski DM, Stiehl DP, Wenger RH, Camenisch G.
    Mol Cell Biol; 2007 May 01; 27(10):3758-68. PubMed ID: 17353276
    [Abstract] [Full Text] [Related]

  • 15. Investigating the dependence of the hypoxia-inducible factor hydroxylases (factor inhibiting HIF and prolyl hydroxylase domain 2) on ascorbate and other reducing agents.
    Flashman E, Davies SL, Yeoh KK, Schofield CJ.
    Biochem J; 2010 Mar 15; 427(1):135-42. PubMed ID: 20055761
    [Abstract] [Full Text] [Related]

  • 16. Oxygen sensing by the prolyl-4-hydroxylase PHD2 within the nuclear compartment and the influence of compartmentalisation on HIF-1 signalling.
    Pientka FK, Hu J, Schindler SG, Brix B, Thiel A, Jöhren O, Fandrey J, Berchner-Pfannschmidt U, Depping R.
    J Cell Sci; 2012 Nov 01; 125(Pt 21):5168-76. PubMed ID: 22946054
    [Abstract] [Full Text] [Related]

  • 17. Short-term effects of pharmacologic HIF stabilization on vasoactive and cytotrophic factors in developing mouse brain.
    Schneider C, Krischke G, Keller S, Walkinshaw G, Arend M, Rascher W, Gassmann M, Trollmann R.
    Brain Res; 2009 Jul 14; 1280():43-51. PubMed ID: 19450570
    [Abstract] [Full Text] [Related]

  • 18. Identification of a region on hypoxia-inducible-factor prolyl 4-hydroxylases that determines their specificity for the oxygen degradation domains.
    Villar D, Vara-Vega A, Landázuri MO, Del Peso L.
    Biochem J; 2007 Dec 01; 408(2):231-40. PubMed ID: 17725546
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.